AZD1390 Administration of a Microdose [11C]AZD1390 to healthy volunteers

Trial Identifier: D6940C00001
Sponsor: AstraZeneca
Collaborator:
Karolinska Institutet, Quintiles IMS
NCTID:: NCT03215381
Start Date: October 2017
Primary Completion Date: February 2018
Study Completion Date: February 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
Swedish Translation

Trial Locations

Country Location
Sweden Stockholm, Sweden, 171 76